The Muscogee Nation's new Tulsa hospital is now offering monoclonal antibody treatment, an outpatient procedure meant to help prevent individuals with mild-to-moderate COVID-19 from requiring hospitalization.
“Research is showing monoclonal antibody infusions are extremely effective in preventing COVID-19 symptoms from worsening,” said Shawn Terry, Secretary of Health for the Muscogee Nation, in a statement. “It is our hope this regional infusion center will help alleviate the current strain on our hospitals by preventing additional severe cases of COVID-19."
The 65-suite clinic at the Council Oak Comprehensive Health Care hospital, located at the former Tulsa Cancer Treatment Centers of America site, provides the antibody infusions, which take about two hours, by appointment to both enrolled Tribal citizens and non-Native Oklahomans who meet certain risk criteria.
More information is available at the Muscogee Nation Department of Health website.
